2014
DOI: 10.1517/14728222.2014.981155
|View full text |Cite
|
Sign up to set email alerts
|

G-protein-coupled receptor type A heteromers as an emerging therapeutic target

Abstract: GPCR heteromers have the potential to open a completely new field for pharmacology with likely a major impact in molecular medicine. Novel pharmacological strategies for the treatment of several pathologies have already been proposed. However, several challenges still exist to accurately characterize the role of the identified heteroreceptor complexes in pathology and to develop heteromer-specific ligands capable of efficiently exploiting their pharmacological features.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
46
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 40 publications
(47 citation statements)
references
References 171 publications
1
46
0
Order By: Relevance
“…The vast majority of subsequent investigations, although each characterized by points of strength and weakness, provided consistent evidence in support of this proposal (see Milligan, 2009;Guidolin et al, 2015;Farran, 2017, for reviews) and the need for a broader view on intercellular communication. Indeed, allosteric RRI made possible through receptor oligomerization may lead to novel receptor dynamics during which the receptor protomers change their recognition, pharmacology, signaling, and trafficking and novel allosteric binding sites can develop (Agnati et al, 2010b;Fuxe et al, 2012;Fuxe and Borroto-Escuela, 2016).…”
Section: Discussionmentioning
confidence: 76%
See 4 more Smart Citations
“…The vast majority of subsequent investigations, although each characterized by points of strength and weakness, provided consistent evidence in support of this proposal (see Milligan, 2009;Guidolin et al, 2015;Farran, 2017, for reviews) and the need for a broader view on intercellular communication. Indeed, allosteric RRI made possible through receptor oligomerization may lead to novel receptor dynamics during which the receptor protomers change their recognition, pharmacology, signaling, and trafficking and novel allosteric binding sites can develop (Agnati et al, 2010b;Fuxe et al, 2012;Fuxe and Borroto-Escuela, 2016).…”
Section: Discussionmentioning
confidence: 76%
“…Homodimers are pairs of the same protomer, whereas heterodimers are formed from distinct GPCR. The number of described homodimers and heterodimers in both cellular systems and native tissues is at present very high (see Fuxe et al, 2015;Guidolin et al, 2015;Borroto-Escuela et al, 2017; Farran, 2017, for reviews), and Table 1 only provides some example. However, the evidence that a GPCR can exploit multiple interaction interfaces can significantly influence the architecture of the resulting receptor complexes in at least two aspects: -The first concerns the stoichiometry of the complex (i.e.…”
Section: Quaternary Structure Of Gpcr Complexesmentioning
confidence: 99%
See 3 more Smart Citations